Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.102757
Revised: March 2, 2025
Accepted: March 10, 2025
Published online: August 15, 2025
Processing time: 290 Days and 9.9 Hours
The study by Luo et al published in the World Journal of Gastrointestinal Oncology presents a thorough and scientific methodology. Pancreatic cancer is the most challenging malignancy in the digestive system, exhibiting one of the highest mortality rates associated with cancer globally. The delayed onset of symptoms and diagnosis often results in metastasis or local progression of the cancer, thereby constraining treatment options and outcomes. For these patients, prompt tumour identification and treatment strategising are crucial. The present objective of pancreatic cancer research is to examine the correlation between various pathological types and imaging data to facilitate therapeutic decision-making. This study aims to clarify the correlation between diverse pathological markers and imaging in pancreatic cancer patients, with prospective longitudinal studies potentially providing novel insights into the diagnosis and treatment of pan
Core Tip: This study validates and extends previous findings regarding the imaging characteristics of pancreatic cancer. In a larger cohort, comprehensive imaging assessments using diverse modalities and rigorous statistical analysis facilitate more precise quantification of these features. It aids in the development of more accurate image-based diagnostic algorithms for pancreatic cancer, which can guide treatment decisions and enhance screening and monitoring protocols for high-risk patients.
